These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6736552)

  • 1. Lead in cerebrospinal fluid and its relationship to plasma lead in humans.
    Cavalleri A; Minoia C; Ceroni M; Poloni M
    J Appl Toxicol; 1984 Apr; 4(2):63-5. PubMed ID: 6736552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases.
    Kapaki E; Segditsa J; Zournas C; Xenos D; Papageorgiou C
    Experientia; 1989 Dec; 45(11-12):1108-10. PubMed ID: 2599056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal tissue distribution of lead in amyotrophic lateral sclerosis.
    Conradi S; Ronnevi LO; Vesterberg O
    J Neurol Sci; 1976 Oct; 29(2-4):259-65. PubMed ID: 978210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal distribution of lead in amyotrophic lateral sclerosis--reestimation of lead in the cerebrospinal fluid.
    Conradi S; Ronnevi LO; Nise G; Vesterberg O
    J Neurol Sci; 1980 Dec; 48(3):413-8. PubMed ID: 7441289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis.
    Leonardi A; Abbruzzese G; Arata L; Cocito L; Vische M
    J Neurol; 1984; 231(2):75-8. PubMed ID: 6737012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant Levels of Cystatin C in Amyotrophic Lateral Sclerosis: a Systematic Review and Meta Analysis.
    Zhu Y; Yang M; Li F; Li M; Xu Z; Yang F; Liu Y; Chen W; Zhang Y; Xu R
    Int J Biol Sci; 2018; 14(9):1041-1053. PubMed ID: 29989057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis.
    Roos PM; Lierhagen S; Flaten TP; Syversen T; Vesterberg O; Nordberg M
    Exp Biol Med (Maywood); 2012 Jul; 237(7):803-10. PubMed ID: 22859739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: A case-control study.
    Vinceti M; Filippini T; Mandrioli J; Violi F; Bargellini A; Weuve J; Fini N; Grill P; Michalke B
    J Trace Elem Med Biol; 2017 Sep; 43():121-125. PubMed ID: 28089071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated cerebrospinal fluid and plasma homocysteine levels in ALS.
    Valentino F; Bivona G; Butera D; Paladino P; Fazzari M; Piccoli T; Ciaccio M; La Bella V
    Eur J Neurol; 2010 Jan; 17(1):84-9. PubMed ID: 19659753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis.
    Roos PM; Vesterberg O; Syversen T; Flaten TP; Nordberg M
    Biol Trace Elem Res; 2013 Feb; 151(2):159-70. PubMed ID: 23225075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid.
    Perry TL; Krieger C; Hansen S; Eisen A
    Ann Neurol; 1990 Jul; 28(1):12-7. PubMed ID: 2375629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Watanabe S; Kimura T; Suenaga K; Wada S; Tsuda K; Kasama S; Takaoka T; Kajiyama K; Takeda M; Yoshikawa H
    J Neurol Sci; 2009 Oct; 285(1-2):146-8. PubMed ID: 19595376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
    Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid from patients with amyotrophic lateral sclerosis inhibits sonic hedgehog function.
    Drannik A; Martin J; Peterson R; Ma X; Jiang F; Turnbull J
    PLoS One; 2017; 12(2):e0171668. PubMed ID: 28170441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead concentrations in blood, plasma, erythrocytes, and cerebrospinal fluid in amyotrophic lateral sclerosis.
    Stober T; Stelte W; Kunze K
    J Neurol Sci; 1983 Sep; 61(1):21-6. PubMed ID: 6631450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
    Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
    Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis.
    Camu W; Billiard M; Baldy-Moulinier M
    Acta Neurol Scand; 1993 Jul; 88(1):51-5. PubMed ID: 8372631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.